Send to

Choose Destination
Clinicoecon Outcomes Res. 2012;4:67-78. doi: 10.2147/CEOR.S16675. Epub 2012 Mar 6.

Cost considerations in the management of atrial fibrillation - impact of dronedarone.

Author information

Heart Rhythm Program, Southlake Regional Health Center, Newmarket, Ontario, Canada.


Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is associated with significant morbidity and mortality. At the societal level, AF carries an enormous cost. Strategies aimed at reducing AF morbidity and mortality and containing the associated fiscal burden are of paramount importance. This review will discuss AF treatment strategies and economics, focusing on the impact of dronedarone, a novel antiarrhythmic agent.


ablation; antiarrhythmic; costs; heart failure; rhythm control

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center